EECP® Therapy Newsletter Archive

Volume 5, Issue 1



Highlights

  • Enhanced External Counterpulsation (EECP®) And Diabetes
  • Reviewing The CMS Coverage Guidelines
  • Upcoming ACC/AHA Angina Guidelines Update
  • EECP® Therapy Patient Story
  • EECP® Therapy Center Spotlight

Volume 4, Issue 1



Highlights

  • A Comparison Of Enhanced External Counterpulsation (EECP®)Therapy with Ranolazine (Ranexa®) for the Treatment of Refractory Angina
  • FDA 510(k) Clearance on Four New Ambulatory Monitoring Devices
  • Reimbursement update

Volume 3, Issue 1

3

Highlights

  • Learn about the results of randomized controlled studies in EECP® Therapy
  • The EECP® Therapy iPhone application
  • Reimbursement update

Volume 2, Issue 1

21

Highlights

  • Learn how your patients can benefit from a repeat course of EECP® treatment
  • Vasomedical receives FDA 510(k) clearance for holter monitoring products

Volume 1, Issue 1

1

Highlights

  • Cardiac syndrome X patients may benefit from EECP® Therapy

©2017 Vaso Corporation